A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
Markovic SN, Geyer SM, Dawkins F, Sharfman W, Albertini M, Maples W, Fracasso PM, Fitch T, Lorusso P, Adjei AA, Erlichman C.
Markovic SN, et al.
Cancer. 2005 Jun 15;103(12):2584-9. doi: 10.1002/cncr.21108.
Cancer. 2005.
PMID: 15887220
Free article.
Clinical Trial.